5 Dividend Aristocrats Where Analysts See Capital Gains

ETF Channel analysis of SPDR S&P Dividend ETF holdings identified five 'Dividend Aristocrat' stocks—ABM Industries, UGI Corp., Medtronic PLC, Brady Corp, and Nordson Corp.—that offer significant implied total return potential despite their consistent dividend growth. These companies, which have increased dividends for over 20 years, show 12-month average analyst target upsides ranging from 23.27% to 35.80%, translating to total return potential between 24.17% and 37.74% when including current dividend yields, suggesting they are not 'fully priced' and could provide substantial capital gains alongside growing income.

Analysis

An analysis of the SPDR S&P Dividend ETF holdings has identified five 'Dividend Aristocrat' stocks—ABM Industries (ABM), UGI Corp. (UGI), Medtronic (MDT), Brady Corp (BRC), and Nordson Corp. (NDSN)—that appear undervalued relative to analyst consensus estimates. These companies, each with a track record of over 20 consecutive years of dividend increases, exhibit significant potential for capital appreciation, a trait not always present in such well-regarded income stocks. According to data from Zacks Investment Research, the potential 12-month upside to average analyst price targets ranges from 23.27% for NDSN to 35.80% for ABM. When factoring in current dividend yields, the implied total return potential is substantial, ranging from 24.17% to 37.74%. A closer look at their dividend growth reveals considerable variance; while Brady Corp's TTM dividend grew a modest 1.60%, Nordson Corp. demonstrated robust growth of 16.88%, highlighting different fundamental momentums within this select group.

Key Decisions for Investors

• Investors seeking total return from stable, income-generating equities should evaluate these five identified Dividend Aristocrats, as their significant upside to analyst targets suggests they may be undervalued despite their quality perception.
• It is crucial to differentiate among the five stocks based on their recent dividend growth momentum, which varies from 1.60% (BRC) to a strong 16.88% (NDSN), as this may signal differing prospects for future total returns.
• Since the investment thesis is heavily reliant on the accuracy of analyst price targets, investors should closely monitor for any revisions to consensus estimates, as negative changes would directly erode the calculated total return potential.